Comparative Effectiveness of Valoctocogene Roxaparvovec and Efanesoctocog Alfa in the Treatment of Severe Hemophilia A: A Matching-Adjusted Indirect Comparison of Bleeding Frequency.

Adv Ther · 2025 · PMC12579684 · PMID 40924278

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the proportion with zero treated spontaneous bleeds was higher in those treated with valoctocogene roxaparvovec, this result did not reach statistical significance (OR 1.90, 95% CI 0.69–5.02) (Fig. 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.